{"id":"68ga-cbp8-pet-mri","safety":{"commonSideEffects":[{"rate":null,"effect":"Radiation exposure"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It is used in PET/MRI imaging to visualize and diagnose prostate cancer. The [68Ga]CBP8 compound binds to PSMA, allowing for the detection of PSMA-expressing cells in the body.","oneSentence":"This drug is a radiopharmaceutical that targets the PSMA protein.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:58:07.040Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prostate cancer diagnosis and imaging"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["No other names"],"phase":"phase_3","status":"active","brandName":"[68Ga]CBP8 PET/MRI","genericName":"[68Ga]CBP8 PET/MRI","companyName":"Brigham and Women's Hospital","companyId":"brigham-and-women-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is a radiopharmaceutical that targets the PSMA protein. Used for Prostate cancer diagnosis and imaging.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}